Download PDF format

Instructions to authors
1.0	Scope of the Journal:
	The journal primarily aims to publish research work in the area of phytopharmacology and clinical reports of herbal drugs. The journal also accepts articles on phytochemistry, quality control and agronomy of medicinal plants. Special emphasis is given to research work related to bioactivity directed fractionation of plant extracts leading to novel bioactive molecules.
2.0	Scope of acceptance:
	The journal accepts reviews, short reviews, full papers, short communications, book reviews, letters to the editor and a brief note section called bioassay reports.
3.0	Submission of manuscripts:
	3.1	Where to submit?
		The articles should be submitted to
			The editor, Journal of Natural Remedies Plot No. 5B, Veerasandra Indl. Area 19th K.M. Stone, Hosur Road, Bangalore - 560 100, India. E-mail:  jnr@naturalremedy.com
	3.2	How to submit? :
		The papers must be in good English and should not have been published elsewhere. The manuscript should be typed double spaced in Windows Word format,there should be atleast 3 cm margin all around. All papers have to be submitted by email only. Figures have to be submitted in TIFF/JPEG format and the resolution should be 300 kb. For accepted articles containing photographs,original photographs have to be provided at the time of publication. All papers are subjected to peer review.
	3.3	Review article :
		These should be within the scope of the journal. Reviews could be short reviews covering a particular matter or full-length articles providing comprehensive information. The contributors are requested to consult the editor in advance before submitting the review article.
	3.4	Full length papers :
•	The title - It must be a full title. Names and affiliations of all the authors to be indicated. Provide full address including e-mail, fax, and telephone of the corresponding author.
•	Abstract - The abstract should present a summary of the problem, scientific method, major findings and conclusion in not more that 250 words and in one paragraph. The abstract need not be structured for manuscript submitted from January 06’ onwards. .
•	Key Words - The author should provide 3 to 6 key words, characterizing the scope of the paper, the main plant material used and the central aspect of the work.
•	Introduction - This should be brief. Indicate clearly the aim of the study and the essential back-ground information.
•	Materials and methods - These should be presented with clarity and detail. Sufficient details should be provided so that the results can be reproduced, if required. The plant material used must be clearly defined with respect to the site of collection, collected fresh or dry, time of collection, authentication and place of deposit of voucher specimens. The pharmacological experimental procedures should be accompanied with data for positive controls. All animal experiments should be humane, in accordance with the NIH guidelines (NIH publication No. 80-23; revised 1978). The editorial board will reject papers if there is any doubt about cruelty to animals.
•	Results - The data should be presented in a coherent sequence so that the report develops clearly and logically. The same data should not be presented in tabular and graphic forms. Please avoid unnecessary use of graphs and tables. Data should not be interpreted or discussed in results section. However, in some cases results and discussion could be combined as one section.
•	Discussion - Discuss the principal conclusions drawn from the results and their important implications. Information presented under results should not be repeated. The discussion should not be unnecessarily lengthy and verbose.
•	References - Should be referred by a number in the text, listed according to this numbering at the end of the paper. Unpublished data should not be cited in the references. The references should comprise the following information and in the order as given in the examples below:
	Examples:
		Journal
		1) Jaiswal AK, Bhattacharya SK. (1992) Indian J. Pharmacol. 24: 12-17. 2) Godhwani S, Godhwani JL, Vyas DS. (1997) J. Ethnopharmacol. 21: 153-163. 3) Reddy DS. (1997) Indian J. Pharmacol. 29: 208-221.
		Books
		1) Snedcor GW, Cochran WG. (1967) Statistical Methods, The Iowa State University Press: Iowa, USA; 1-10. 2) Mehara E, Vaidya MC. (1993) In: Talwar GP, Gupta SK. (Eds.) A Handbook of Practical and Clinical Immunology, CBS Publishers: New Delhi; 2-20.
•	Tables - Tables should be typed on separate sheets and should bear a short descriptive title.
•	Figures - These must be numbered and cited in the text. Mark clearly in the margin of the manuscript where the figure is to be inserted. Photographs must be black and white, glossy prints. The legends for the figures should be typed on a separate sheet of paper. Authors of accepted manuscripts are required to submit the actual values of figures for computer redrawing in the editorial office.
•	Proofs - It will be sent to the corresponding author only. These should be corrected and returned as soon as possible.
•	Reprints - Fifteen reprints will be provided free of charge to the corresponding author. Additional reprints can be provided on payment basis.
	3.5	Short Communication:
		These should be brief communications, preferably not exceeding two to three A4 size papers. It should be structured as abstract, introduction, material and methods, results, discussion and references.
	3.6	Bioassay reports :
		This section contains concise reports on in-vitro pharmacological assays of medicinal plants and their derivatives. Bioassay reports will have the following subsections; Abstract, objective of the study, plant material used, preparation of extracts / pure compound, tested activity, results, conclusion and references. Data in this section should be restricted to two A4 size pages.
	3.7	Letters to the editor:
		These should be comments on previously published articles and brief original communication not exceeding 1000 words plus one figure or table.
	Note:
		Antimicrobial reports will be accepted only as short communication. Studies should be designed to indicate MIC values and not zone of inhibition. Papers with extracts showing MIC values >500 µg/ml will not be accepted. Anti-microbial reports which are too preliminary will not be accepted.